|
| Press Releases |
|
 |
|
| Tuesday, July 23, 2024 |
|
|
Avance Clinical Appoints Asia Regional Director as Part of Global Expansion Program |
| Avance Clinical, the award-winning CRO for biotechs, is proud to announce the appointment of Jessica Han as Director, Asian Operations based out of Avance Clinical's Seoul, Korea office. more info >> |
|
| Tuesday, June 4, 2024 |
|
|
New Research Launched at BIO24 Finds CROs with In-house Regulatory Affairs Can Deliver 30% Savings, Halve Timelines and Cut Risks for Biotechs |
| Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, is sharing new data at BIO 2024 from Frost & Sullivan research showing biotechs save more than 30% in costs and halve start-up times with CROs that have in-house scientific and regulatory affairs. more info >> |
|
| Friday, May 31, 2024 |
|
|
Avance Clinical Expands Specialist CNS, Cardiometabolic, and Rare Diseases CRO Services in Europe with Julius Clinical |
| Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs has signed a Memorandum of Understanding (MOU) with Julius Clinical, a leading CNS, cardiometabolic, and rare diseases specialist CRO with extensive site relationships in the region. more info >> |
|
| Wednesday, May 8, 2024 |
|
|
Avance Clinical Expands Further into APAC with New Clinical Operations in South Korea |
| Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, will attend BIO Korea (May 8-10, 2024) and formally open new clinical operations in Seoul, South Korea. more info >> |
|
| Friday, April 19, 2024 |
|
|
Avance Clinical Showcases Clinical Excellence at World Orphan Drug Conference in Boston, April 23-25 |
| Avance Clinical, the award-winning North American and Australian market-leading CRO for biotechs, will attend World Orphan Drug Conference in Boston (April 23-25, 2024) to share their rare diseases drug development expertise with biotechs (booth #730). more info >> |
|
| Thursday, March 28, 2024 |
|
|
Avance Clinical at World Vaccine Congress to Share Latest Vaccine Clinical Trial News Including an HIV-1 Study |
| Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, will attend World Vaccine Congress in Washington DC (April 1-4, 2024) and share the latest clinical trial client news including the Uvax Bio announcement. (Booth #267) more info >> |
|
| Wednesday, February 28, 2024 |
|
|
Avance Clinical CEO Talks with SCRIP about US Biotech Sector "Green Shoots" and a New CRO Report |
| Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, has today spoken with SCRIP about their positive outlook for the US biotech sector following the J.P. Morgan Healthcare Conference and Biotech Showcase meetings. (read the full article here) more info >> |
|
| Friday, January 12, 2024 |
|
|
Latest Analysis Reveals 65% of US Biotechs Struggle to Identify Suitable CRO Partner |
| Avance Clinical, the leading Australian and North American CRO for biotechs announced today that new industry analysis shows 60-65% of US biotechs face challenges identifying the right sized CRO partner that can deliver at every phase of their drug development program. The report found this directly affected clinical programs and budgets. more info >> |
|
| Thursday, October 19, 2023 |
|
|
Avance Clinical Invited to Brief 45 Korean Biotechs on Their GlobalReady Drug Development Pathway from Korea and Australia to the US |
| more info >> |
|
| Tuesday, May 30, 2023 |
|
|
Avance Clinical at ASCO & BIO 2023: Early Phase Oncology Trials Increasingly Elaborate and Demand More Patients |
| Avance Clinical, the leading award-winning Australian and North American CRO that offers ClinicReady and GlobalReady for early phase biotech companies to speed up the path to regulatory approval, says early phase oncology studies are increasingly more complex and demand more patients. more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
Business of IP Asia Forum and Entrepreneur Day Unlock IP and Innovation Potential
Dec 8, 2024 17:21 HKT/SGT
|
|
|
Dida Inc. Enters Strategic Partnership with JD Auto and JD Allianz Insurance to Explore Automotive Aftermarket Opportunities
Dec 6, 2024 20:22 HKT/SGT
|
|
|
DIFC announces decarbonation strategy, achieving Net Zero by 2045 at Future Sustainability Forum 2024 
Dec 6, 2024 18:52 HKT/SGT
|
|
|
HKTDC and Hang Seng Bank's InnoClub Recognises and Supports Outstanding GBA Start-ups
Dec 6, 2024 15:36 HKT/SGT
|
|
|
Innovation Takes Center Stage at the 2024 EE Awards Asia Ceremony
Dec 6, 2024 13:30 HKT/SGT
|
|
|
JCB Becomes Sole Sponsor of New Large-Scale Japanese-Themed Establishment in Plaza Senayan, Jakarta's Luxury Mall
Dec 6, 2024 14:00 JST
|
|
|
JCB Signs Memorandum of Understanding with Kobe Tourism Bureau for Inbound Tourism Promotion
Dec 6, 2024 14:00 JST
|
|
|
FYNTRA Group Partners with Spectral Capital to Pioneer Quantum Wallet Technology
Dec 6, 2024 10:33 HKT/SGT
|
|
|
BIP Asia Forum and Entrepreneur Day opens today
Dec 6, 2024 00:09 HKT/SGT
|
|
|
DesignInspire opens today with free access for industry professionals and the public
Dec 5, 2024 23:34 HKT/SGT
|
|
|
HAIN, the Power of Turkish Cinema
Dec 5, 2024 22:00 HKT/SGT
|
|
|
Shaping Airports for Tomorrow: The 8th edition of inter airport Southeast Asia Returns to Singapore in 2025
Dec 5, 2024 15:59 HKT/SGT
|
|
|
DIFC opens 2nd Future Sustainability Summit to accelerate global transition to low-carbon, climate-stable future
Dec 5, 2024 15:38 HKT/SGT
|
|
|
CISO Sydney 2025: Uniting Cybersecurity Leaders for a Safer Future
Dec 5, 2024 13:08 HKT/SGT
|
|
|
"LEQEMBI" (Lecanemab) Approved for the Treatment of Early Alzheimer's Disease in Mexico
Dec 5, 2024 11:22 JST
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
